Literature DB >> 12435450

Artemisinin: mechanisms of action, resistance and toxicity.

Steven R Meshnick1.   

Abstract

Artemisinin and its derivatives are widely used throughout the world. The mechanism of action of these compounds appears to involve the heme-mediated decomposition of the endoperoxide bridge to produce carbon-centred free radicals. The involvement of heme explains why the drugs are selectively toxic to malaria parasites. The resulting carbon-centred free radicals are alkylate heme and proteins, one of which is the translationally controlled tumour protein. Clinically relevant artemisinin resistance has not been demonstrated, but it is likely to occur since artemisinin resistance has been obtained in laboratory models. At high doses, artemisinin can be neurotoxic but toxicity has not been found in clinical studies. The mechanism of neurotoxicity may be similar to the mechanism of action.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12435450     DOI: 10.1016/s0020-7519(02)00194-7

Source DB:  PubMed          Journal:  Int J Parasitol        ISSN: 0020-7519            Impact factor:   3.981


  156 in total

Review 1.  Schistosomiasis--a century searching for chemotherapeutic drugs.

Authors:  Gabriela Ribeiro-dos-Santos; Sergio Verjovski-Almeida; Luciana C C Leite
Journal:  Parasitol Res       Date:  2006-04-25       Impact factor: 2.289

2.  Artemisinin and heme.

Authors:  Steven R Meshnick
Journal:  Antimicrob Agents Chemother       Date:  2003-08       Impact factor: 5.191

Review 3.  Therapy of falciparum malaria in sub-saharan Africa: from molecule to policy.

Authors:  Peter Winstanley; Stephen Ward; Robert Snow; Alasdair Breckenridge
Journal:  Clin Microbiol Rev       Date:  2004-07       Impact factor: 26.132

4.  The antimalarial drug artemisinin alkylates heme in infected mice.

Authors:  Anne Robert; Françoise Benoit-Vical; Catherine Claparols; Bernard Meunier
Journal:  Proc Natl Acad Sci U S A       Date:  2005-09-09       Impact factor: 11.205

5.  Efficacy of artemether and artesunate in mice infected with praziquantel non-susceptible isolate of Schistosoma japonicum.

Authors:  Wei Wang; Tian-Yu Li; Yuan Ji; Guo-Li Qu; Yi-Li Qian; Hong-Jun Li; Jian-Rong Dai; You-Sheng Liang
Journal:  Parasitol Res       Date:  2013-12-11       Impact factor: 2.289

6.  Pharmacokinetics of the Antischistosomal Lead Ozonide OZ418 in Uninfected Mice Determined by Liquid Chromatography-Tandem Mass Spectrometry.

Authors:  Anna Leonidova; Mireille Vargas; Jörg Huwyler; Jennifer Keiser
Journal:  Antimicrob Agents Chemother       Date:  2016-11-21       Impact factor: 5.191

7.  Artemisinin reduces human melanoma cell migration by down-regulating alpha V beta 3 integrin and reducing metalloproteinase 2 production.

Authors:  Elisabetta Buommino; Adone Baroni; Nunzia Canozo; Marcella Petrazzuolo; Rosario Nicoletti; Antonio Vozza; Maria Antonietta Tufano
Journal:  Invest New Drugs       Date:  2008-10-28       Impact factor: 3.850

Review 8.  21st century natural product research and drug development and traditional medicines.

Authors:  Linh T Ngo; Joseph I Okogun; William R Folk
Journal:  Nat Prod Rep       Date:  2013-04       Impact factor: 13.423

9.  Haemin enhances the in vivo efficacy of artemether against juvenile and adult Schistosoma mansoni in mice.

Authors:  Naglaa Mohamed El-Lakkany; Sayed Hassan Seif El-Din
Journal:  Parasitol Res       Date:  2013-02-28       Impact factor: 2.289

10.  Artemisinin resistance in Plasmodium falciparum: A process linked to dormancy?

Authors:  Qin Cheng; Dennis E Kyle; Michelle L Gatton
Journal:  Int J Parasitol Drugs Drug Resist       Date:  2012-01-27       Impact factor: 4.077

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.